NEW YORK (Reuters Health) – Brentuximab vedotin can be safely combined with the second-line triple-agent chemotherapy regimen most commonly used in the U.S. for relapsed
Read moreHome »
Overweight children and adolescents receiving chemotherapy for treatment of leukemia are less successful battling the disease compared to their lean peers. Now, research conducted at
Read moreGynecomastia is a condition where men develop abnormally large breasts. The enlargement is not of fat but breast tissues. Anatomy of breasts Breasts in men
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KYTRIL® TABLETS CMI 20170915 pronounced (Kai-tril) contains the active ingredient granisetron hydrochloride
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LYNPARZA® olaparib Consumer Medicine Information What is in this leaflet This leaflet
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EMEND® IV Fosaprepitant dimeglumine Consumer Medicine Information What is in this leaflet
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OGIVRI® contains the active ingredient trastuzumab (rch) Consumer Medicine Information What is
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. IMOJEV® Consumer Medicine Information (CMI) summary The full CMI on the next
Read moreFor people who‘ve undergone treatments for cancer, hair loss is a common but nevertheless stressful side effect. And, contrary to popular belief, the hard part
Read moreDespite the great advances in cancer research in recent years, treatments that can cause very severe adverse effects are still used. This is the case
Read more